RxDoctor Payments Data

Chukwuma Ukata

Primary Podiatric Medicine · Garner, NCNPI 1275630295

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 49 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Paratek Pharmaceuticals, Inc. at 25.4% of the total. That places this record below the midpoint for primary podiatric medicine clinicians in NC, where the typical reported total is $1,305.

$896in general payments, 2019–2025

Across 49 payments — averaging $18.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paratek Pharmaceuticals, Inc.$228
  • Organogenesis Inc.$168
  • Amgen$158
  • Smith+Nephew$78
  • Medtronic$75
  • Alfasigma USA, Inc.$47
  • plus $142 from 7 others

What the payments were for

  • Food & beverage$896100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Paratek Pharmaceuticals, Inc.14$228
Organogenesis Inc.8$168
Amgen(2 entities)9$158
Smith+Nephew3$78
Medtronic4$75
Alfasigma USA, Inc.3$47
Nevro Corp.2$40
Convatec Inc.1$26
Globus Medical1$20
Orpyx Medical Technologies US Inc.1$19
Polarityte, Inc.1$16
Merck1$13
Cardiovascular Systems Inc.1$9

How this compares

$896 in reported general payments places this provider in the 40th percentile of 64 primary podiatric medicine providers in North Carolina.

See all primary podiatric medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$68,098
Medicare patients
218
Services billed
1,060

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate81$2,051
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip41$1,051
Ciclopirox24$663
Ketoconazole15$281
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav18$186
Cephalexin12$120

Paid to pharmacies, not to this prescriber.

Other primary podiatric medicine in Garner

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →